Filing Details

Accession Number:
0001209191-22-042766
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-20 18:18:38
Reporting Period:
2022-07-18
Accepted Time:
2022-07-20 18:18:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1845337 Day One Biopharmaceuticals Inc. DAWN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655962 Ii N Charles York 395 Oyster Point Blvd, Suite 217
South San Francisco CA 94080
Coo, Cfo And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-18 2,500 $20.00 331,365 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021.